XORTX Therapeutics Inc (XRTX)
2.59
-0.31
(-10.75%)
USD |
NASDAQ |
Apr 25, 16:00
2.70
+0.11
(+4.25%)
After-Hours: 07:21
XORTX Therapeutics Free Cash Flow (Quarterly): -1.078M for Sept. 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | -1.078M |
June 30, 2023 | -1.740M |
March 31, 2023 | -2.504M |
December 31, 2022 | -3.484M |
September 30, 2022 | -0.9722M |
June 30, 2022 | -1.900M |
March 31, 2022 | -2.506M |
December 31, 2021 | -3.115M |
September 30, 2021 | -0.0243M |
June 30, 2021 | -0.7202M |
March 31, 2021 | -0.9268M |
December 31, 2020 | 1.144M |
September 30, 2020 | -0.1254M |
June 30, 2020 | -0.1985M |
March 31, 2020 | -1.403M |
December 31, 2019 | -0.082M |
September 30, 2019 | 0.0079M |
June 30, 2019 | -0.0345M |
March 31, 2019 | -0.0878M |
December 31, 2018 | -0.0358M |
September 30, 2018 | -0.1782M |
Date | Value |
---|---|
June 30, 2018 | -0.1955M |
March 31, 2018 | -0.7626M |
December 31, 2017 | |
November 30, 2017 | -0.0276M |
September 30, 2017 | |
August 31, 2017 | -0.0596M |
May 31, 2017 | -0.0386M |
March 31, 2017 | -0.0055M |
February 28, 2017 | -0.027M |
November 30, 2016 | -0.087M |
August 31, 2016 | -0.0047M |
May 31, 2016 | -0.0226M |
February 29, 2016 | -0.0125M |
November 30, 2015 | -0.1444M |
August 31, 2015 | -0.0093M |
May 31, 2015 | -0.0015M |
February 28, 2015 | -0.0873M |
November 30, 2014 | 0.0012M |
August 31, 2014 | 0.0002M |
May 31, 2014 | -0.0236M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.484M
Minimum
Dec 2022
1.144M
Maximum
Dec 2020
-1.092M
Average
-0.9495M
Median
Free Cash Flow (Quarterly) Benchmarks
ImmunoPrecise Antibodies Ltd | -0.3825M |
Acasti Pharma Inc | -1.892M |
Aurinia Pharmaceuticals Inc | 14.25M |
Edesa Biotech Inc | -1.406M |
Lexaria Bioscience Corp | -0.6766M |